INQToday: Duterte will attend Senate drug war probe - Dela Rosa | Inquirer

INQToday: Duterte will attend Senate drug war probe – Dela Rosa

/ 09:03 PM October 22, 2024

Former Senator Leila de Lima faces the House of Representatives’ quad committee panel as it continues to investigate the alleged extrajudicial killings committed during the administration of former President Rodrigo Duterte.

Signal number 2 is raised in several areas of Luzon and Visayas as Tropical Storm Kristine intensifies. 

Article continues after this advertisement

Former President Rodrigo Duterte will attend the Senate probe on his war on drugs “regardless of who is presiding,” according to Senator Ronald “Bato” Dela Rosa.

FEATURED STORIES

Vice President Sara Duterte is accusing Department of Justice Secretary Jesus Crispin Remulla of not knowing the law and being slow, after Remulla announced that Duterte has violated moral principles because of her recent statements against the body of late former President Ferdinand Marcos Sr.

Vice President Sara Duterte is accepting calls for her to undergo a mental health examination, but only if  2025 election candidates will take drug tests.

Article continues after this advertisement

Senior Deputy Majority Leader and Ilocos Norte 1st District Rep. Sandro Marcos breaks his silence over Vice President Sara Duterte’s tirades against his family, saying she “crossed the line” with her “bizarre temper tantrum” towards the dead.

The Pasig City Regional Trial Court Branch 159 grants the Senate panel on women’s request for detained televangelist Apollo Quiboloy to attend the chamber’s public hearing on Wednesday, October 23.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

MOST READ
TAGS: Apollo Quiboloy, House quad committee, Rodrigo Duterte, Sara Duterte

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.